logo
Dr Martens to widen range and cut discounts in quest for profits

Dr Martens to widen range and cut discounts in quest for profits

Times05-06-2025
The boss of Dr Martens has pledged to ween the struggling bootmaker off discounting, push into new markets and promote other product lines and as it looks to return to profit growth this year.
The FTSE 250 retailer said its previous narrow focus on its boots, which accounts for roughly half of the group's total sales, 'failed to take full advantage' of its shoes, sandals and leather goods offering, adding that its direct-to-consumer approach 'led to a loss of coverage and responsiveness in our wholesale offering'.
Ije Nwokorie, who succeeded Kenny Wilson as chief executive at the start of the year, told shareholders he plans to shift the business from a 'channel-first to a consumer-first mindset'.
'The strategy that the business had … broke growth in boots, built awareness around the world, but the market shifted away from boots,' he said.
Online sales of shoes, mules and sandals grew last year, while sales of its boots, known for their yellow stitching, declined at its shops.
He added that his strategy was not 'rocket science', but was about 'broadening our focus to give people more reason to buy our products'. 'We need to become a business that is no longer reliant on any single market, product or channel,' he said.
Nwokorie did not expand on what markets he planned for Dr Martens to move into, but said expansion would take place in the year ahead. The company also planned to reduce discounting across its ecommerce and wholesale channels as it aimed to drive full price sales.
Nwokorie's turnaround plans were unveiled alongside the group's full-year results.
Dr Martens said sales to consumers in the US returned to growth in the second half of the year and continued to increase, but cautioned that UK revenues remained lower since the year end 'due to a challenging market'.
Revenues in the year to the end of March fell 10 per cent to £787.6 million, down from £877 million a year earlier. Adjusted pre-tax profit dropped 64 per cent to £34.1 million, which was above the City's forecasts of £30.6 million. Inventory reduction helped lower net debt, excluding lease liabilities, to £94.1 million, down from £177.5 million a year ago.
For the present financial year, management expects to deliver profits in line with market expectations of £54 million to £74 million.
The Northamptonshire bootmaker has been facing persistent challenges in America, its largest market, including a slowdown in sales as consumers reduced spending and supply chain problems at its distribution centre in Los Angeles. That episode forced the brand to lease temporary third-party warehousing.
Shares in the heritage brand, which have fallen more than 80 per cent since listing in 2021 after the company issued multiple profit warnings, were up 15p, or 25 per cent 11¼p, to 75p in afternoon trading as the market reacted to its turnaround pledge. Analysts at Investec believed the strategy 'should unlock a material profit growth story' and its financial targets were realistic.
Despite uncertainty around President Trump's tariff regime, Nwokorie said there were no plans to shift production from the US at this point.
Dr Martens has shifted its supply chain away from China and expects to produce 62 per cent of its autumn/winter collection in Vietnam, where imports into the US face tariffs of up to 46 per cent. Before the possible tariff introduction, the company said most of its autumn/winter collection would be in transit or in the US by the start of July.
Nwokorie said: 'We've looked at different scenarios, but we're dealing with the reality in front of us and we feel confident about our ability to ride these waves,' adding that the company would keep average selling prices for its spring/summer and autumn/winter collections unchanged in the US market.
Ije Nwokorie: a 'visionary brand storyteller'
While not one of the biggest names in the retail community, Ije Nwokorie has demonstrated to industry observers and City analysts that he knows the power behind the British heritage brand.
News of his appointment as chief executive of Dr Martens, announced last April, did not come as too much of a surprise to the market, with some in the City speculating that Nwokorie's appointment as chief brand officer in November 2023 was part of a wider succession plan.
As part of the newly created chief brand officer post, Nwokorie was responsible for setting the 'overall brand strategy, vision and direction for the next phase of Dr Martens' growth' — not a bad idea for the retailer that has failed to replicate the influence and sales of its sturdy boots in America that it has in Britain.
The former Dr Martens boss Kenny Wilson, who Nwokorie replaced, has described his successor as a 'visionary brand storyteller' whose passion for the bootmaker makes him 'the ideal person to lead the next era'.
Nwokorie, who took up his post in February last year, was a senior director at Apple Retail, where he worked from January 2018.
He has been on the Dr Martens board since January 2021, when it listed its shares on the London Stock Exchange, amid booming demand for its shoes. Before that, Nwokorie had spent 11 years at Wolff Olins, the global brand consultancy, where he rose to become chief executive.
As part of Nwokorie's hopes to drive a brand refresh, he has been quick to up the ante in his leadership team. Last week he announced that Carla Murphy would join the group as chief brand officer from Adidas, where she served as the footwear giant's global senior vice-president. Murphy, who starts in July, will be responsible for looking after Dr Martens' brand, its 'most important asset', Nwokorie said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'Most comfortable shoe in the world' drops price of its most classic style by 40%
'Most comfortable shoe in the world' drops price of its most classic style by 40%

North Wales Live

time11 minutes ago

  • North Wales Live

'Most comfortable shoe in the world' drops price of its most classic style by 40%

Amongst the Dr Martens online sale of up to 40% off designs across the site, the 1460 Burgundy Smooth Leather Lace Up Boots have had a reduction of over £65. The 1460 is the original Dr Martens design, a true classic and the one everyone picures when they think about the famous brand. Made of smooth leather that shapes around your foot, the boots are durable famously lasting a long time ensuring that you never need to buy another pair again - unless you want a new colour. Originally £159 the 1460 Burgundy Smooth Leather Lace Up Boots are now on sale for 40% less at just £95 with sizes 3-13 in stock. For money-saving tips, First produced on April, 1 1960 - where the shoe got its name - the 1460 was made originally for workers but "soon became a cultural icon". Customers have been loving the classic style boots for decades and with over 10,000 reviews have awarded them a 4.6 stars on the Dr Martens website. One buyer wrote: "The best product I have ever experienced. I've been wearing Dr Martens for the last 40 years of my life. The quality has never changed. Most comfortable shoes in the world. In my opinion. May they continue to be." Another stated: "So comfortable! Looks fantastic, great color (burgundy). Very comfortable even on the first wear. However some customers didn't love the stiffness of the boot when you first buy them. One said: "Lovely quality boots. Very stiff so needs a bit of wearing to get comfortable. Previously Got black soft leather and wore them instantly with no issues. Need to wear these in, which is taking time." Although another customer said: "Love them! First time I bought some for me and I was worried they would take time to wear in but watta ya know, so comfortable from the outset!" Alternatively, Clarks have 60% off the Orinoco 2 Style Boot Dark Brown Leather that are now £48 down from £120.

Healthcare boosts UK's FTSE 100 as earnings, Fed meeting in focus
Healthcare boosts UK's FTSE 100 as earnings, Fed meeting in focus

Reuters

time41 minutes ago

  • Reuters

Healthcare boosts UK's FTSE 100 as earnings, Fed meeting in focus

July 29 (Reuters) - Britain's FTSE 100 closed higher on Tuesday, led by healthcare shares, as investors assessed mixed corporate updates and awaited the Federal Reserve's next policy decision on Wednesday. The benchmark index (.FTSE), opens new tab rose 0.6%. Healthcare stocks (.FTNMX201030), opens new tab gained 2.2% after AstraZeneca (AZN.L), opens new tab beat second-quarter revenue and profit expectations. Shares of the drugmaker climbed 3.4%. Heavyweight bank stocks (.FTNMX301010), opens new tab advanced 1.5%, tracking gains in European peers. Barclays (BARC.L), opens new tab gained 2.8% after the British lender's first-half profit rose by a better-than-expected 23%. Europe's bank stocks rose to their highest level since September 2008 as investors bet on improved profits and resilience in an industry broadly insulated from tariff turmoil. Precious metal miners (.FTNMX551030), opens new tab led sectoral gains with a 2.4% rise as gold prices steadied after hitting their lowest level since July 9 on Monday. Conversely, chemical stocks (.FTNMX552010), opens new tab lost 5.4%, pressured by Croda International's (CRDA.L), opens new tab 10.4% fall, after the chemical company reported first-half sales below estimates. Industrial miners (.FTNMX551020), opens new tab lost 1.3%, tracking lower copper prices. Glencore (GLEN.L), opens new tab and Anglo American (AAL.L), opens new tab fell 3.4% and 1.6% respectively. Among other individual stocks, Games Workshop (GAW.L), opens new tab surged 5.4% to top the FTSE 100 index, after the miniature wargames maker reported a nearly 30% jump in annual pre-tax profit. The domestically-focused midcap FTSE 250 index (.FTMC), opens new tab closed down 0.7%, pressured by Inchcape's (INCH.L), opens new tab 11.7% fall after the car distributor reported a 4% drop in first-half adjusted pre-tax profit at constant currency. Greggs (GRG.L), opens new tab slipped 4.7% after reporting a 14% fall in first-half profit. On trade, U.S. Commerce chief Howard Lutnick said on Tuesday that President Donald Trump would make his trade deal decisions this week, even as separate negotiations with China and the European Union continue. U.S. and EU officials were still discussing steel and aluminium tariffs as well as digital services regulations. Trump also flagged a "world tariff" rate of 15% to 20% on Monday for countries that were not negotiating a deal, among the highest rates since the Great Depression of the 1930s. Focus will be on the U.S. central bank's policy meeting, which is expected to leave rates unchanged on Wednesday.

First British-bred blueberry title claimed… then swiftly lost
First British-bred blueberry title claimed… then swiftly lost

Telegraph

time41 minutes ago

  • Telegraph

First British-bred blueberry title claimed… then swiftly lost

Few things stir the spirit like a national first – so when the James Hatton Institute, in Invergowrie, declared this summer that it had produced the UK's first home-bred blueberry, heads were turned. However, no sooner had the institute made the announcement than it discovered that someone had beaten it. It was then forced to relinquish the title of a British first in favour of proclaiming the first Scottish-bred blueberry. The institute had proudly unveiled Highland Charm, a blueberry variety bred on Scottish soil, produced after a decade of research, cross-breedings and a large amount of patience. But instead of relishing in the sweet taste of triumph, the institute had to content with a bitter reality. Highland Charm would fall short of claiming the crown of first UK-bred blueberry, as that accolade had been collected by another pioneer whose identity remains a mystery. The institute issued a correction after being contacted by the people behind the true first British-bred variety, and clarified that it instead had the first blueberry of Scottish heritage. But sources in the berry industry robustly denied that any other berry breeding programmes existed nationwide. Instead, they suggested that the name confusion could have been prompted by the Scottish Government, which reportedly funded the breeding programme, and therefore asserted Scotland's claim on the produce. The Scottish Government denied these accusations, with a spokesman advising that 'it was changed because someone else approached them claiming to have created the UKs first bred blueberry before them'. Waitrose boasted of British blueberries in 2020 but fell short of claiming they were bred here saying instead that they were organically grown. But for institute staff who have spent over 10 years working on Highland Charm, one honest mistake will not get in the way of their celebrations. Susan McCallum, the organisation's resident blueberry breeder, said: 'It combines high yields, excellent fruit size, outstanding flavour, with a balanced sugar-acid profile and a satisfying bite. Growers are really excited about it.' Nick Marston, of British Berry Growers, welcomed the news of a new home-bred strain, saying: 'The potential advantage that breeding in the UK offers is that new varieties will be selected and trialled in the UK climate at an early stage in their development which means they may be better suited to our climatic conditions.' The long process of berry breeding means that growers can brand it a 'Scottish Berry', suited to the weather and native. At present, growers must rely on foreign varieties, and whilst they can be grown in the UK they cannot truly call themselves a native-bred fruit. Tesco reported last year that consumers enjoy more than 60,000 tonnes of blueberries per year, with almost 90 per cent imported from abroad – largely the Americas – a number of weeks after they were harvested. Researchers at Invergowrie wanted to change that with Highland Charm, a resilient and high-yielding seed that has delivered in testing across different seasons and growing conditions both home and abroad. Now it is undergoing a licencing process to allow it to qualify as a new cultivar, meaning Highland Charm could be on supermarket shelves in the next two to three years. Ms McCallum hopes its success will encourage consumers to buy locally produced, in-season produce, and promised: 'They're fresher and have higher health benefits than imported berries that take six weeks to get from field to shelves. You'll taste the difference.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store